This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| France Psoriasis | |
|---|---|
| Name | France Psoriasis |
| Formation | 1991 |
| Type | Patient advocacy organization |
| Headquarters | Paris, France |
| Region served | France |
France Psoriasis is a French patient association dedicated to representing and supporting people affected by psoriasis and psoriatic arthritis. The association engages with national institutions, European networks, and international research consortia to influence policy, clinical practice, and public awareness. France Psoriasis operates through local chapters, professional partnerships, and collaborations with health ministries and academic centers.
France Psoriasis was founded in 1991 amid growing advocacy movements in France and the broader European Union health civil society landscape. Its establishment followed dialogues involving stakeholders from Assistance Publique–Hôpitaux de Paris, patient advocates active in the aftermath of debates around biologic therapies, and clinicians from institutions such as Hôpital Saint-Louis and Institut Pasteur. Early campaigns paralleled initiatives led by organizations like World Health Organization, European Commission, and national groups including Haute Autorité de Santé and the Ministry of Solidarity and Health (France), aligning with international patient networks such as European Federation of Psoriasis Associations and advocacy efforts connected to conferences like the European Academy of Dermatology and Venereology meetings. Over subsequent decades, France Psoriasis engaged with pharmaceutical stakeholders including Novartis, AbbVie, and Pfizer while coordinating with academic centers at Université de Paris and clinical trial units at INSERM.
France Psoriasis states its mission to improve quality of life for people with psoriasis and psoriatic arthritis by combining patient advocacy, awareness-raising, and support for clinical research. Its activities encompass information dissemination alongside cooperation with regulatory bodies such as the Agence nationale de sécurité du médicament et des produits de santé and participation in policy consultations involving the Conseil d’État and parliamentary health committees within the Assemblée nationale (France). The association promotes patient-centered care models referenced in guidelines from the European Medicines Agency and collaborates with specialty societies like the French Society of Dermatology and the European League Against Rheumatism.
France Psoriasis is governed by an elected board composed of patient representatives, clinicians, and legal advisers, and operates under French nonprofit law (association loi 1901). The structure includes a central office in Paris with regional delegations linked to university hospitals in cities such as Lyon, Marseille, Bordeaux, Lille, and Toulouse. Leadership interacts with institutional partners including CNRS research groups, hospital departments at Hôpital Cochin, and professional associations like the French Society of Rheumatology. Oversight mechanisms reflect reporting practices aligned with standards from organizations such as the European Patients' Academy and governance guidance used by NGOs participating in European Health Forum Gastein.
France Psoriasis has mounted public campaigns addressing stigma and access to care, often timed with international observances like World Psoriasis Day and coordinated with global actors including International Federation of Psoriasis Associations. Campaign themes have intersected with policies debated in the Conseil constitutionnel and public debates involving media outlets such as Le Monde, Le Figaro, and France Télévisions. Initiatives have targeted screening and referral pathways via partnerships with primary care networks affiliated to Ordre des Médecins and community pharmacies represented by Conseil national de l'Ordre des pharmaciens, and have lobbied for reimbursement frameworks overseen by Caisse Nationale d'Assurance Maladie.
France Psoriasis collaborates with academic researchers and clinical trial consortia at INSERM, Université Paris Cité, and research hospitals including Hôpital Saint-Antoine. Partnerships extend to multinational study groups affiliated with European Medicines Agency protocols and joint projects with industry partners such as UCB, Bristol Myers Squibb, and Eli Lilly and Company. The association contributes patient-reported outcome measures used in trials presented at meetings of the American Academy of Dermatology and European Academy of Dermatology and Venereology, and participates in registries coordinated with entities like SNDS and hospital biobanks connected to Agence de la biomédecine.
France Psoriasis finances its operations through membership fees, public grants, private donations, and restricted funding from pharmaceutical companies including Novartis, Sanofi, and Amgen. Financial reporting conforms to French nonprofit transparency practices and is subject to audits consistent with requirements applied by entities such as Direction générale des Finances publiques when public subsidies are received. The association seeks diversified funding strategies to balance independence with collaborative research funding models observed in partnerships with European Commission research programmes and foundations like Fondation pour la Recherche Médicale.
France Psoriasis offers patient education materials, peer-support groups, and referral services to specialists at centers of excellence such as Hôpital Saint-Louis and regional university hospitals. Resources include guidance aligned with recommendations from the European Academy of Dermatology and Venereology, patient leaflet collaborations with organizations like International Psoriasis Council, and digital tools compatible with platforms promoted by Haute Autorité de Santé. The association connects patients to legal aid services interfacing with agencies like Pôle Emploi and social services offices, and maintains outreach via partnerships with media outlets including RTL (French radio), France Inter, and health journalism in Libération.
Category:Medical and health organizations based in France